Back to User profile » Dr Anna Miller-Larsson
Papers published by Dr Anna Miller-Larsson:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3055-3064
Published Date: 19 October 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2
Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI
Journal of Inflammation Research 2013, 6:109-119
Published Date: 20 August 2013
![Noteworthy Comment: The findings provide evidence that budesonide, a commonly used steroid to combat inflammation, can reduce tissue damage by affecting the production of potentially destructive enzymes.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation
Fang Q, Schulte NA, Kim H, Kobayashi T, Wang X, Miller-Larsson A, Wieslander E, Toews ML, Liu X, Rennard SI
Journal of Inflammation Research 2013, 6:25-33
Published Date: 27 February 2013